Serum fibroblast growth factor 21 and triglycerides independently predict the development of type 2 diabetes

被引：0
|
作者：
Angelin, B. [1 ]
Hilding, A. [1 ]
Ostenson, C. -G. [1 ]
Bina, H. A. [2 ]
Kharitonenkov, A. [2 ]
Rudling, M. [1 ]
机构：
[1] Karolinska Inst, Dept Endocrinol Metab & Diabet, Stockholm, Sweden
[2] Lilly Res Labs, Indianapolis, IN USA
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
256
引用
收藏
页码：S112 / S113
页数：2
相关论文
共 50 条
  • [1] The serum fibroblast growth factor 21 is correlated with retinopathy in patients with type 2 diabetes mellitus
    Heidari, Zahra
    Hasanpour, Mahdieh
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)
  • [2] Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
    Yang Xiao
    Lingjiao Liu
    Aimin Xu
    Pengcheng Zhou
    Zhaofeng Long
    Yiting Tu
    Xiaoyan Chen
    Weili Tang
    Gan Huang
    Zhiguang Zhou
    [J]. Cardiovascular Diabetology, 14
  • [3] Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes
    Xiao, Yang
    Liu, Lingjiao
    Xu, Aimin
    Zhou, Pengcheng
    Long, Zhaofeng
    Tu, Yiting
    Chen, Xiaoyan
    Tang, Weili
    Huang, Gan
    Zhou, Zhiguang
    [J]. CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [4] Fibroblast Growth Factor 21 in Gestational Diabetes Mellitus and Type 2 Diabetes Mellitus
    Gawlik, Katarzyna
    Milewicz, Tomasz
    Pawlica-Gosiewska, Dorota
    Trznadel-Morawska, Iwona
    Solnica, Bogdan
    [J]. JOURNAL OF DIABETES RESEARCH, 2023, 2023
  • [5] SERUM LEVELS OF FIBROBLAST GROWTH FACTOR 21 IN TYPE 2 DIABETIC PATIENTS
    Panahi, Y.
    Bonakdaran, S.
    Yaghoubi, M. A.
    Keramati, M. R.
    Haratian, M.
    Sahebkar, A.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2016, 12 (03) : 257 - 261
  • [6] The association of serum fibroblast growth factor 21 with insulin secretory function and metabolic parameters in type 2 diabetes
    Kim, M. -J.
    Kim, M. -K.
    Song, I.
    Kim, H.
    Choi, Y. -K.
    Bae, K. -H.
    Park, K. -G.
    Lee, I. -K.
    Lee, J. -E.
    Jung, E.
    Kim, E.
    [J]. DIABETOLOGIA, 2014, 57 : S245 - S245
  • [7] Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes
    Kim, Won Jin
    Kim, Sang Soo
    Lee, Han Cheol
    Song, Sang Heon
    Bae, Min Jung
    Yi, Yang Seon
    Jeon, Yun Kyung
    Kim, Bo Hyun
    Kim, Yong Ki
    Kim, In Joo
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (05) : 586 - 590
  • [8] Association of serum fibroblast growth factor 21 and urinary glucose excretion in hospitalized patients with type 2 diabetes
    Zhang, Rui
    Cai, Xiaoling
    Du, Yongrui
    Liu, Liu
    Han, Xueyao
    Liu, Wei
    Gong, Siqian
    Zhou, Xianghai
    Wang, Xiangqing
    Wen, Xin
    Ji, Linong
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (01)
  • [9] Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes
    Gao, Ruo-Yao
    Hsu, Bang-Gee
    Wu, Du-An
    Hou, Jia-Sian
    Chen, Ming-Chun
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2019, 2019
  • [10] Circulating Fibroblast Growth Factor 21 Levels Predict Progressive Kidney Disease in Subjects With Type 2 Diabetes and Normoalbuminuria
    Lee, C. H.
    Hui, E. Y. L.
    Woo, Y. C.
    Yeung, C. Y.
    Chow, W. S.
    Yuen, M. M. A.
    Fong, C. H. Y.
    Xu, A.
    Lam, K. S. L.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (04): : 1368 - 1375
12345